Bharat Biotech's Intra Nasal Vaccine BBV154 Safe, Well-tolerated, and Immunogenic in Clinical Trials
Hyderabad: Bharat Biotech International Limited (BBIL), a global leader in vaccine innovation and developer of vaccines for infectious diseases, today announced that BBV154 (intra nasal vaccine) has…
